KRAS-targeting drugs show promise for rare appendix cancer

Targeting mutant KRAS may offer a promising new treatment option for appendix cancer, according to research from The University of Texas MD Anderson Cancer Center published in the Journal of Hematology & Oncology.

Q&A: Rise in cyclosporiasis cases

Cyclosporiasis is a gastrointestinal illness caused by the microscopic parasite Cyclospora. People contract cyclosporiasis by consuming food or water contaminated with feces containing Cyclospora parasites. Health officials ...

page 3 from 40